ArticleClinical and experimental immunology2013

Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels.

L Semerano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.